Adiso Therapeutics
MA - ConcordBiotechnology
Focus: Adiso Therapeutics is a biotechnology company focused on live bacterial treatments, headquartered in Concord, MA. The company operates in an emerging and specialized segment of therapeutic development.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Adiso Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Adiso Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
BT051 200 mg
Ulcerative ColitisClinical Trials (1)
NCT05084261An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)
Phase 1Help build intelligence for Adiso Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.